Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $71.55 USD
Change Today +1.30 / 1.85%
Volume 586.5K
RMD On Other Exchanges
Symbol
Exchange
New York
OTC US
Frankfurt
Frankfurt
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

resmed inc (RMD) Key Developments

ResMed Launches AirSense 10 Autoset for Her: a Complete Integrated Sleep Solution for Women Living with Sleep Apnoea

ResMed Inc. has announced the European launch of the AirSense 10 AutoSet for Her, the first range of treatments designed to provide an integrated sleep solution specifically for women living with obstructive sleep apnoea (OSA). Featuring built-in wireless connectivity and advanced comfort technologies, the AutoSet for Her delivers a unique, clinically proven,[2] auto-adjusting algorithm designed to treat mild-to-moderate sleep apnoea in women. To complement the AirSense 10 AutoSet for Her device, is the newly launched range of ultra-light and compact masks, the AirFit for Her offering the perfect fit tailored to the female anatomy.

ResMed's AirView Patient Management System to Directly Integrate with Brightree's Home Medical Equipment Billing and Business Management Software Solution

ResMed and Brightree announced ResMed's AirView patient management system will directly integrate with Brightree's leading home medical equipment (HME) billing and business management software solution. The AirView-Brightree integration is the latest connectivity achievement in ResMed and Brightree's longstanding relationship, and is one of multiple enhancements planned for this year. Past advances have included Brightree integration with ResMed's U-Sleep® premium sleep compliance solution, as well as a data exchange agreement allowing HMEs to order ResMed equipment directly from the Brightree platform. This direct integration was made possible by the ResMed Data Exchange program, a comprehensive suite of software and service solutions that allows for the integration of valuable sleep and respiratory treatment data from ResMed's AirView and U-Sleep patient management platforms with electronic medical records, billing, and care management applications. AirView and U-Sleep are part of the ResMed Air Solutions suite of sleep and respiratory products that provide physicians, HMEs and patients with the tools and data that can support improved workflow efficiencies and patient outcomes.

ResMed Inc. Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:05 AM

ResMed Inc. Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:05 AM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: David Pendarvis, Chief Administrative Officer, Global General Counsel and Secretary.

ResMed Inc. Declares Quarterly Dividend, Payable on March 19, 2015

ResMed Inc. declared a quarterly dividend of $0.28 per share, with a record date of February 12, 2015 and payable on March 19, 2015.

ResMed Inc. Reports Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended December 31, 2014

ResMed Inc. reported unaudited consolidated earnings results for second quarter and six months ended December 31, 2014. For the quarter, the company reported net revenue of $422,952,000 against $384,341,000 a year ago. Income from operations was $109,146,000 against $105,020,000 a year ago. Income before income tax was $115,511,000 against $109,461,000 a year ago. Net income was $91,181,000 against $86,636,000 a year ago. Diluted earnings per share were $0.64 against $0.60 a year ago. Cash flow from operations was $106.0 million. For the six months, the company’s net revenue was $803,351,000 against $742,003,000 a year ago. Income from operations was $203,821,000 against $201,903,000 a year ago. Income before income tax was $217,441,000 against $211,530,000 a year ago. Net income was $174,440,000 against $167,566,000 a year ago. Diluted earnings per share were $1.22 against $1.15 a year ago. Net cash provided by operating activities was $192,538,000 against $174,590,000 a year ago. Purchase of property, plant and equipment was $39,675,000 against $36,426,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RMD:US $71.55 USD +1.30

RMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $32.49 USD +0.55
IDEXX Laboratories Inc $153.17 USD +3.02
Mettler-Toledo International Inc $323.29 USD +4.41
Cooper Cos Inc/The $186.17 USD +1.08
Varian Medical Systems Inc $93.74 USD +0.87
View Industry Companies
 

Industry Analysis

RMD

Industry Average

Valuation RMD Industry Range
Price/Earnings 29.0x
Price/Sales 6.2x
Price/Book 6.3x
Price/Cash Flow 27.8x
TEV/Sales 5.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESMED INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.